Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

  title={Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.},
  author={Mark J. Pletcher and Lawrence D. Lazar and Kirsten Bibbins-Domingo and Andrew Moran and Nicolas Rodondi and Pamela G. Coxson and James M Lightwood and Lawrence G. Williams and Lee W Goldman},
  journal={Annals of internal medicine},
  volume={150 4},
Context Which lipid-lowering policies with statins are cost-effective? Contribution This modeling exercise found that the Adult Treatment Panel III guidelines, which recommend treatment based on cholesterol level and estimated coronary heart disease risk, are reasonably cost-effective if statins cost about $1.50 to $2.20 per pill. At costs lower than $0.10 per pill, treating all persons with LDL cholesterol levels greater than 3.4 mmol/L (>130 mg/dL) could be a better strategy. Implication… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 107 extracted citations


Publications referenced by this paper.
Showing 1-10 of 59 references

A systematic review and economic evaluation of statins for the prevention of coronary events

S Ward, M Lloyd Jones, +3 authors A Ryan
Health Technol Assess • 2007
View 4 Excerpts
Highly Influenced

Statin safety: a systematic review.

The American journal of cardiology • 2006
View 5 Excerpts
Highly Influenced

Interim Projections by Age, Sex, Race, and Hispanic Origin. Washington, DC: U.S

U.S.U.S. Census Bureau
Census Bureau; • 2008
View 1 Excerpt

Primary prevention of cardiovascular disease: cost-effectiveness comparison

OH Franco, AJ der Kinderen, C De Laet, A Peeters, L. Bonneux
Int J Technol Assess Health Care. 2007;23:71-9 • 2007

Similar Papers

Loading similar papers…